Inventor · disambiguated record
David Matthew Wilson
Also filed as: WILSON DAVID · WILSON DAVID M · WILSON DAVID MATTHEW
32 granted patents·24 pending applications·237 citations·filing 1999–2019
96Inventor score
Files withGLAXO GROUP LTD19SMITHKLINE BEECHAM PLC9GLAXOSMITHKLINE IP DEV LTD4ATKINSON FRANCIS LOUIS3ANCLIFF RACHAEL ANN2
Top patents by PatentIndex Score
56 records- 0193US10653676B2Small molecule inhibitors of USP1 deubiquitinating enzyme activityDANA FARBER CANCER INST INC·Filed 2016·Granted May 19, 2020·9 cites·12 claims
- 0289US8697725B2Tetrahydroquinoline derivatives and their pharmaceutical useDEMONT EMMANUEL HUBERT·Filed 2010·Granted Apr 15, 2014·19 cites·17 claims
- 0388US9518032B2Small molecule inhibitors of USP1 deubiquitinating enzyme activityD'ANDREA ALAN D·Filed 2011·Granted Dec 13, 2016·14 cites·3 claims
- 0486US8691747B2Method of treatment based on ATAD2 inhibitorsKRUIDENIER LAURENS·Filed 2011·Granted Apr 8, 2014·21 cites·1 claims
- 0586US7348339B2Imidazopyridine derivatives as kinase inhibitorsGLAXO GROUP LTD·Filed 2003·Granted Mar 25, 2008·44 cites·11 claims
- 0685US7799773B2Benzazepine derivatives for the treatment of neurological disordersGLAXO GROUP LTD·Filed 2008·Granted Sep 21, 2010·7 cites·19 claims
- 0785US7704994B2Benzazepine derivatives for the treatment of neurological disordersGLAXO GROUP LTD·Filed 2007·Granted Apr 27, 2010·6 cites·14 claims
- 0885US7199137B2Imidazole derivatives as Raf kinase inhibitorsSMITHKLINE BEECHAM PLC·Filed 2001·Granted Apr 3, 2007·21 cites·19 claims
- 0983US7615550B2Substituted piperazines,(1,4) diazepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine H1 and/or H3 antagonists or histamine H3 reverse antagonistsGLAXO GROUP LTD·Filed 2003·Granted Nov 10, 2009·17 cites·19 claims
- 1082US6987119B2Imidazol-2-carboxamide derivatives as raf kinase inhibitorsSMITHKLINE BEECHAM PLC·Filed 2001·Granted Jan 17, 2006·20 cites·9 claims
- 1180US10039755B22-(azaindol-2-yl) benzimidazoles as PAD4 inhibitorsGLAXO GROUP LTD·Filed 2017·Granted Aug 7, 2018·2 cites·9 claims
- 1279US9833449B22-(azaindol-2-yl) benzimidazoles as PAD4 inhibitorsGLAXO GROUP LTD·Filed 2016·Granted Dec 5, 2017·2 cites·20 claims
- 1379US9518054B22-(azaindol-2-yl) benz imidazoles as PAD4 inhibitorsGLAXO GROUP LTD·Filed 2015·Granted Dec 13, 2016·2 cites·9 claims
- 1479US8633319B27-(1H-pyrazol-4-yl)-1,6-naphthyridine compounds as Syk inhibitorsATKINSON FRANCIS LOUIS·Filed 2011·Granted Jan 21, 2014·6 cites·11 claims
- 1578US7696193B2Benzazepine derivatives for the treatment of neurological disordersGLAXO GROUP LTD·Filed 2003·Granted Apr 13, 2010·8 cites·5 claims
- 1678US7375105B2Pyridine substituted furan derivatives as Raf kinase inhibitorsSMITHKLINE BEECHAM PLC·Filed 2002·Granted May 20, 2008·11 cites·6 claims
- 1774US7888347B2Pyrazolo [3,4-D]azepine derivatives as histamine H3 antagonistsGLAXO GROUP LTD·Filed 2006·Granted Feb 15, 2011·2 cites·11 claims
- 1871US8394969B2Cyclic benzimidazole derivatives useful as anti-diabetic agentsBOOKSER BRETT C·Filed 2009·Granted Mar 12, 2013·4 cites·19 claims
- 1970US9127003B22-(azaindol-2-yl)benzimidazoles as PAD4 inhibitorsATKINSON STEPHEN JOHN·Filed 2012·Granted Sep 8, 2015·2 cites·14 claims
- 2065US6358491B1Somatostatin analogsBERLEX LAB·Filed 1999·Granted Mar 19, 2002·20 cites·45 claims
- 2162US10815218B2Benzoimidazole derivatives as PAD4 inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2019·Granted Oct 27, 2020·0 cites·12 claims
- 2259US2010075953A1Substituted piperazines, (1,4) diazepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonistsGLAXO GROUP LTD·Filed 2009·Application pending·0 cites
- 2356US8993560B2CompoundsATKINSON FRANCIS LOUIS·Filed 2012·Granted Mar 31, 2015·0 cites·14 claims
- 2455US2008108615A1Imidazole-2-Carboxamide Derivatives as Raf Kinase InhibitorsSMITHKLINE BEECHAM PLC·Filed 2007·Application pending·0 cites
- 2553US9447074B2CompoundsGLAXO GROUP LTD·Filed 2015·Granted Sep 20, 2016·0 cites·20 claims
- 2653US2007244123A1Heterocycle-carboxamide derivatives as raf kinase inhibitorsSMITHKLINE BEECHAM PLC·Filed 2007·Application pending·0 cites
- 2752US2007135433A1Imidazole derivatives as raf kinase inhibitorsDEAN DAVID K·Filed 2007·Application pending·0 cites
- 2850US2016355505A1Novel compoundsGLAXO GROUP LTD·Filed 2016·Application pending·0 cites
- 2949US7282500B2Imidazole-2-carboxamide derivatives as Raf kinase inhibitorsSMITHKLINE BEECHAM PLC·Filed 2002·Granted Oct 16, 2007·0 cites·5 claims
- 3048US2004192689A1Heterocycle-carboxamide derivatives as raf kinase inhibitorsFiled 2002·Application pending·0 cites
- 3148US2014024558A1Method of TreatmentGLAXO GROUP LTD·Filed 2013·Application pending·0 cites
- 3246US2009306052A1Indenyl derivatives and use thereof for the treatment of neurological disordersGLAXO GROUP LTD·Filed 2005·Application pending·0 cites
- 3345US8410284B2Cyclic benzimidazole derivatives useful as anti-diabetic agentsDANG QUN·Filed 2009·Granted Apr 2, 2013·0 cites·17 claims
- 3445US8207331B2Benzazepine derivatives for the treatment of neurological disordersBAMFORD MARK JAMES·Filed 2010·Granted Jun 26, 2012·0 cites·18 claims
- 3544US10407407B2Benzoimidazole derivatives as PAD4 inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Sep 10, 2019·0 cites·16 claims
- 3644US2015203851A1Inhibitors of bromodomain-containing protein pcaf for the treatment of autoimmune and inflammatory diseases or for the treatment of cancerGLAXO GROUP LTD·Filed 2013·Application pending·0 cites
- 3744US2006205774A14-(4-(Heterocyclylakoxy) phenyl-1-(heterocyclyl-carbonyl) piperidine derivavites and related compounds as histamine h3 antagonists for the treatment of neurological diseases such as alzheimer'sBAMFORD MARK J·Filed 2004·Application pending·0 cites
- 3844US2007185089A1Benzazepine derivatives for the treatment of neurological and psychiatric disordersGLAXO GROUP LTD·Filed 2005·Application pending·0 cites
- 3943US7446106B2Pyridylfurans and pyrroles as Raf kinase inhibitorsSMITHKLINE BEECHAM PLC·Filed 2002·Granted Nov 4, 2008·0 cites·8 claims
- 4043US2006019964A1CompoundsANCLIFF RANCHAEL A·Filed 2005·Application pending·0 cites
- 4143US2007060566A1Benzazepine derivatives as histamine h3 antagonistsBAILEY NICHOLAS·Filed 2004·Application pending·0 cites
- 4242US9624219B2Compound (S) and (R)-N-(2-fluoropyridin-4-yl)-3-methyl-2-(5-methyl-2,4-dioxo-1,2-dihydropyrido[3,4-d]pyrimidin-3(4H)-yl)butanamide and useGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Apr 18, 2017·0 cites·9 claims
- 4342US7452906B2Pyridine derivatives as Raf kinase inhibitorsSMITHKLINE BEECHAM PLC·Filed 2002·Granted Nov 18, 2008·0 cites·6 claims
- 4442US7297693B2Nitrogen-containing heterocyclic compounds and their use as Raf inhibitorsSMITHKLINE BEECHAM PLC·Filed 2002·Granted Nov 20, 2007·0 cites·8 claims
- 4542US2008009479A1Tetrahydrobenzazepines as Histamine H3 Receptor LigandsGLAXO GROUP LTD·Filed 2005·Application pending·0 cites
- 4642US2007232590A13-Cylcoalkylbenzazepines as Histamine H3 AntagonistsGLAXO GROUP LTD·Filed 2005·Application pending·0 cites
- 4742US2012202875A1Method Of TreatmentLEE KEVIN·Filed 2010·Application pending·0 cites
- 4842US2008161289A1Fused Thiazole Derivatives Having Affinity for the Histamine H3 ReceptorGLAXO GROUP LTD·Filed 2006·Application pending·0 cites
- 4941US2009105217A12-phenyl-5-amino-1,3,4-oxadiazoles and their use as nicotinic acetylcholine receptor ligandsCOPPO FRANK TEEN·Filed 2007·Application pending·0 cites
- 5041US2006293298A1CompoundsBAMFORD MARK J·Filed 2005·Application pending·0 cites
Showing the top 50 of 56 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when David Matthew Wilson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →